Literature DB >> 6672110

A hypo-osmotic medium to disaggregate tumor cell clumps into viable and clonogenic single cells for the human tumor stem cell clonogenic assay.

A Leibovitz, R Liu, C Hayes, S E Salman.   

Abstract

A hypo-osmolar medium and tissue processing technique is described which is useful for disaggregation of residual human tumor cell clumps persisting after mechanical or enzymatic treatment of solid tumors and malignant effusions. The addition of the hypo-osmolar procedure to the standard methods for disaggregation increased the viable single cell yield in solid tumors by 47% and in malignant effusions by 67%. In 5 of the 26 solid tumor specimens tested in the human tumor stem cell assay, clonogenic single cells were obtained with the hypo-osmolar procedure, whereas no growth was observed using standard methods. Overall, the success rate for clonogenicity increased from 46% to 65% for the 26 solid tumors, with the major improvement occurring in ovarian cancer. Clonogenicity was obtained in 80% of malignant effusions both by standard methods and the hypo-osmolar techniques. The increased total yield of clonogenic cells obtained with this procedure enhances the opportunity for experimental versatility and in vitro drug testing.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6672110     DOI: 10.1002/stem.5530010606

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  4 in total

1.  Exfoliative cytologic evaluation of primary cultured lung carcinomas.

Authors:  J H Resau; C D Albright; J R Cottrell; K L Colombo-Burke; S C Aisner; I Miura; J R Testa
Journal:  Cytotechnology       Date:  1991-06       Impact factor: 2.058

2.  Changes in animal cell natural aggregates in suspended batch cultures.

Authors:  J L Moreira; P M Alves; J G Aunins; M J Carrondo
Journal:  Appl Microbiol Biotechnol       Date:  1994-04       Impact factor: 4.813

3.  A superior method for single cell dispersal of rat and tumorous human anterior pituitary tissue.

Authors:  S L Atkin; A M Landolt; R V Jeffreys; M C White
Journal:  In Vitro Cell Dev Biol       Date:  1993-01

4.  In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell lines.

Authors:  M J Xu; D S Alberts; R Liu; A Leibovitz; Y Liu
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.